Amphetamine and Treatment-resistant depression

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Amphetamine and Treatment-resistant depression

Amphetamine vs. Treatment-resistant depression

Amphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Treatment-resistant depression (TRD) or treatment-refractory depression is a term used in clinical psychiatry to describe cases of major depressive disorder (MDD) that do not respond adequately to appropriate courses of at least two antidepressants.

Antidepressant

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.

Amphetamine and Antidepressant · Antidepressant and Treatment-resistant depression · See more »

Bipolar disorder

Bipolar disorder, previously known as manic depression, is a mental disorder that causes periods of depression and periods of abnormally elevated mood.

Amphetamine and Bipolar disorder · Bipolar disorder and Treatment-resistant depression · See more »

Bupropion

Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication primarily used as an antidepressant and smoking cessation aid.

Amphetamine and Bupropion · Bupropion and Treatment-resistant depression · See more »

Methylphenidate

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Amphetamine and Methylphenidate · Methylphenidate and Treatment-resistant depression · See more »

Monoamine oxidase inhibitor

Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).

Amphetamine and Monoamine oxidase inhibitor · Monoamine oxidase inhibitor and Treatment-resistant depression · See more »

Stimulant

Stimulants (also often referred to as psychostimulants or colloquially as uppers) is an overarching term that covers many drugs including those that increase activity of the central nervous system and the body, drugs that are pleasurable and invigorating, or drugs that have sympathomimetic effects.

Amphetamine and Stimulant · Stimulant and Treatment-resistant depression · See more »

Substance abuse

Substance abuse, also known as drug abuse, is a patterned use of a drug in which the user consumes the substance in amounts or with methods which are harmful to themselves or others, and is a form of substance-related disorder.

Amphetamine and Substance abuse · Substance abuse and Treatment-resistant depression · See more »

Substituted amphetamine

Substituted amphetamines are a class of compounds based upon the amphetamine structure; it includes all derivative compounds which are formed by replacing, or substituting, one or more hydrogen atoms in the amphetamine core structure with substituents.

Amphetamine and Substituted amphetamine · Substituted amphetamine and Treatment-resistant depression · See more »